GCV Asia Congress 2017
Skip Content

19 October 2015

Big Deal: 23andme raises $115m

The genetics testing company has managed to attract a range of corporate investors, partly through its research activities, and international expansion looks to be on the horizon.

Author: Robert Lavine, News Editor

The $115m series E round closed by US-based personal genetics service provider 23andme last week at a $1.1bn valuation, which made it the sector’s first unicorn, showed the potential for companies offering similar services.